Abiraterone D4 | CAS 2122245-62-7 - Request Quote
Abiraterone D4
| SZ CAT No: | SZ-A006D02 |
| CAS No | 2122245-62-7 |
| Mol.F. | C24H27D4NO |
| Mol.Wt. | 353.5 |
| Inv. Status | Synthesis on demand |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Abiraterone D4 is chemically (3S,8R,9S,10R,13S,14S)-10,13-Dimethyl-17-(pyridin-3-yl-d4)-2,3,4,7,8,9,10,11,12,13,14,15-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol. Abiraterone D4 is supplied with detailed characterization data compliant with regulatory guideline. Abiraterone D4 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Abiraterone Acetate.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 2122245-62-7
Purchase 2122245-62-7
Order 2122245-62-7
Enquire 2122245-62-7
price of 2122245-62-7
2122245-62-7 Supplier
2122245-62-7 Manufacturer
2122245-62-7 Exporter
buy high quality Abiraterone D4
Purchase Abiraterone D4
Abiraterone D4 suppliers
Abiraterone D4 manufacturers
Abiraterone D4 price
Order Abiraterone D4
Enquire Abiraterone D4
Abiraterone D4 cost
Abiraterone D4 Supplier
Abiraterone D4 Distributor
Abiraterone D4 for Method Validation
Abiraterone Acetate Reference Standard
Abiraterone D4 for ANDA Filing
Abiraterone D4 for Forced Degradation Studies
Abiraterone D4 Identification Standards
Abiraterone D4 for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.


